Over the 90-day window ending February 19, 2026, Fate Therapeutics's three dominant insider ownership positions are held by Director Group, Llc Redmile (12.88Mn shares), President And Ceo Bahram Valamehr (664.71K shares), Officer Cindy Tahl (487.08K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Group, Llc Redmile | 12,884,277 | 26 Dec, 2024 | |
| Bahram Valamehr | President And Ceo | 664,708 | 16 Jan, 2026 |
| Cindy Tahl | Nan | 487,081 | 16 Jan, 2026 |
| J Scott Wolchko | President And Ceo | 371,248 | 10 Jan, 2024 |
| Jerome Charles Bressi | Nan | 335,203 | 16 Jan, 2025 |
| John Mendlein | 311,231 | 20 Jan, 2023 | |
| Yu-Waye Chu | Chief Medical Officer | 140,676 | 19 Apr, 2023 |
| Mark Plavsic | Chief Technical Officer | 123,705 | 11 Jan, 2023 |
| Edward J Iii Dulac | Chief Financial Officer | 101,479 | 05 Mar, 2024 |
| Kamal Adawi | Chief Financial Officer | 100,000 | 16 Jan, 2026 |
| Brian T. Powl | Chief Commercial Officer | 41,146 | 06 Jul, 2023 |
| Michael Stewart Lee | 11,331 | 13 Jun, 2022 | |
| William H Rastetter | 11,331 | 13 Jun, 2022 | |
| Robert Hershberg | 10,659 | 13 Jun, 2022 | |
| Shefali Agarwal | 10,490 | 13 Jun, 2022 | |
| Timothy Coughlin | 9,892 | 13 Jun, 2022 | |
| Karin Jooss | 9,848 | 13 Jun, 2022 | |
| Yuan Xu | 8,669 | 07 Aug, 2024 | |
| Robert S Epstein | 2,681 | 04 Jun, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Jan, 2026 | Cindy Tahl | Common Stock | A | 100,000 | $0.00 | 487,081 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Common Stock | A | 335,000 | $0.00 | 664,708 | D | A |
| 15 Jan, 2026 | Kamal Adawi | Common Stock | A | 25,000 | $0.00 | 100,000 | D | A |
| 09 Jan, 2026 | Cindy Tahl | Common Stock | D | 10,589 | $1.06 | 387,081 | D | S |
| 09 Jan, 2026 | Bahram Valamehr | Common Stock | D | 5,190 | $1.07 | 329,708 | D | S |
| 20 Oct, 2025 | Kamal Adawi | Common Stock | A | 75,000 | $0.00 | 75,000 | D | A |
| 04 Aug, 2025 | Cindy Tahl | Common Stock | D | 9,037 | $1.06 | 397,670 | D | S |
| 04 Aug, 2025 | Cindy Tahl | - | - | 397,670 | D | |||
| 04 Aug, 2025 | Bahram Valamehr | Common Stock | D | 14,466 | $1.06 | 334,898 | D | S |
| 15 Jan, 2025 | Cindy Tahl | Common Stock | A | 70,000 | $0.00 | 406,707 | D | A |
| 15 Jan, 2025 | Jerome Charles Bressi | Common Stock | A | 65,000 | $0.00 | 335,203 | D | A |
| 10 Jan, 2025 | Cindy Tahl | Common Stock | D | 5,654 | $1.55 | 336,707 | D | S |
| 10 Jan, 2025 | Bahram Valamehr | Common Stock | D | 8,705 | $1.54 | 349,364 | D | S |
| 10 Jan, 2025 | Jerome Charles Bressi | Common Stock | D | 5,980 | $1.55 | 270,203 | D | S |
| 10 Jan, 2025 | Jerome Charles Bressi | - | - | 270,203 | D | |||
| 20 Dec, 2024 | Group, Llc Redmile | - | - | 12,884,277 | I | |||
| 20 Dec, 2024 | Group, Llc Redmile | - | - | 12,827,946 | I | |||
| 20 Dec, 2024 | Group, Llc Redmile | Common Stock | D | 1,084,936 | $1.68 | 11,743,010 | I | J |
| 20 Dec, 2024 | Group, Llc Redmile | Common Stock | A | 397,964 | $1.68 | 12,884,277 | I | P |
| 20 Dec, 2024 | Group, Llc Redmile | - | - | 11,743,010 | I |